Novartis’s Remibrutinib Succeeds In Pivotal CSU Trials With Promise Of Liver Safety

 
• By Ayisha Sharma
  
drawn outline of a liver on a blue background, post it with smiley face
Liver Toxicities Have Plagued Other BTK Inhibitors For Multiple Sclerosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D